James Hardie Industries plc ADR (JHX) concluded trading on Wednesday at a closing price of $23.51, with 4.27 million shares of worth about $100.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.26% during that period and on April 23, 2025 the price saw a gain of about 4.49%. Currently the company’s common shares owned by public are about 429.79M shares, out of which, 429.40M shares are available for trading.
Stock saw a price change of 7.60% in past 5 days and over the past one month there was a price change of -3.05%. Year-to-date (YTD), JHX shares are showing a performance of -23.69% which decreased to -31.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.72 but also hit the highest price of $43.57 during that period. The average intraday trading volume for James Hardie Industries plc ADR shares is 1.57 million. The stock is currently trading 4.21% above its 20-day simple moving average (SMA20), while that difference is down -15.27% for SMA50 and it goes to -28.47% lower than SMA200.
James Hardie Industries plc ADR (NYSE: JHX) currently have 429.79M outstanding shares and institutions hold larger chunk of about 2.06% of that.
The stock has a current market capitalization of $10.10B and its 3Y-monthly beta is at 1.78. PE ratio of stock for trailing 12 months is 23.40, while it has posted earnings per share of $1.00 in the same period. Its PEG reads 6.16 and has Quick Ratio of 1.67 while making debt-to-equity ratio of 0.57. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JHX, volatility over the week remained 4.07% while standing at 5.37% over the month.
Stock’s fiscal year EPS is expected to drop by -7.75% while it is estimated to increase by 5.72% in next year. EPS is likely to shrink at an annualized rate of 3.80% for next 5-years, compared to annual growth of 17.57% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on March 27, 2025 offering a Buy rating for the stock and assigned a target price range of between $27.40 and $27.35 to it. On March 24, 2025, Macquarie Downgrade their recommendations, while on December 10, 2024, Truist Initiated their ratings for the stock with a price target of $45. Stock get an Overweight rating from JP Morgan on November 06, 2024.
